SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-001416
Filing Date
2023-01-13
Accepted
2023-01-13 16:15:25
Documents
1
Period of Report
2023-01-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2860
  Complete submission text file 0001493152-23-001416.txt   4314
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Issuer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 711 STEWART AVENUE SUITE 200 GARDEN CITY NY 11530
Business Address
Morse Robert A. Jr. (Reporting) CIK: 0001960049 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21617 | Film No.: 23528937